HDAC3 inhibitors induce drug resistance by promoting IL-17 A production by T cells

Related articles

1. BCL11B targeting in tumor CD8 ⁺ T cells amplifies anti-tumor response by blocking exhaustion while promoting stemness and cytotoxicity

   This article has 28 authors:

   1. Leonardo Silvane
   2. Tomas Zelenka
   3. Divya P. Talada
   4. Valeriu B. Cismasiu
   5. Shamima Islam
   6. Raghwendra P. Singh
   7. Zefanias Ngove
   8. Sayan Chakraborty
   9. MacLean S. Hall
   10. Jamie L. Blauvelt
   11. Erika Eksioglu
   12. Soraya Zorro Manrique
   13. Joseph O. Johnson
   14. Alyssa N. Obermayer
   15. Alex Alfaro
   16. Wen Huang
   17. Amod Sarnaik
   18. Ahmad A. Tarhini
   19. John E. Mullinax
   20. Erin George
   21. Patrick Hwu
   22. Eduardo Davila
   23. Jose R. Conejo-Garcia
   24. Yenan T. Bryceson
   25. Dung-Tsa Chen
   26. Timothy I. Shaw
   27. Shari Pilon-Thomas
   28. Dorina Avram

2. Regucalcin-containing extracellular vesicles suppress M2 macrophage polarization and attenuate tumor progression in vivo

   This article has 5 authors:

   1. Risako Okada
   2. Kana Tominaga
   3. Takeshi Yamamoto
   4. Masayoshi Yamaguchi
   5. Naoomi Tominaga

3. PRDX1 regulates T cell effector function in the ovarian tumor microenvironment

   This article has 7 authors:

   1. Sarah J. McPhedran
   2. Gillian Carleton
   3. Scott Hannan
   4. Sarah MacPherson
   5. Leonardo Castro
   6. Sam Preshaw
   7. Julian J. Lum